




Searching News Database: Alpha-1 Antitrypsin
HSMN NewsFeed - 29 Sep 2016
Amgen And Arrowhead Pharmaceuticals Announce Two Cardiovascular Collaborations
Amgen And Arrowhead Pharmaceuticals Announce Two Cardiovascular Collaborations
HSMN NewsFeed - 1 Sep 2016
Kamada and Kedrion Seek FDA Approval of Human Rabies Immunoglobulin as a Post-Exposure Treatment
Kamada and Kedrion Seek FDA Approval of Human Rabies Immunoglobulin as a Post-Exposure Treatment
HSMN NewsFeed - 27 Mar 2014
Baxter Announces Plans to Create Two Separate Leading Global Healthcare Companies
Baxter Announces Plans to Create Two Separate Leading Global Healthcare Companies
HSMN NewsFeed - 9 Dec 2013
Kamada Announces Appointment of Amir London as Senior Vice President, Business Development
Kamada Announces Appointment of Amir London as Senior Vice President, Business Development
HSMN NewsFeed - 24 Aug 2010
Baxter Announces Manufacturing, Supply and Distribution Agreement with Kamada for GLASSIA
Baxter Announces Manufacturing, Supply and Distribution Agreement with Kamada for GLASSIA
HSMN NewsFeed - 21 Feb 2008
Talecris Biotherapeutics Celebrates 20th Anniversary of Launch of Prolastin(R)
Talecris Biotherapeutics Celebrates 20th Anniversary of Launch of Prolastin(R)
HSMN NewsFeed - 10 Jan 2008
LFB Biotechnologies to Collaborate with GTC Biotherapeutics on Coagulation Factor IX Program
LFB Biotechnologies to Collaborate with GTC Biotherapeutics on Coagulation Factor IX Program
HSMN NewsFeed - 5 Sep 2006
Extensive Post-License Data Reaffirm Clinical Safety Profile of Prolastin(R)
Extensive Post-License Data Reaffirm Clinical Safety Profile of Prolastin(R)
Additional items found! 9

Members Archive contains
9 additional stories matching:
Alpha-1 Antitrypsin
(Password required)
Alpha-1 Antitrypsin
(Password required)